IMPURITIES AVAILABLE FOR 'Ibrutinib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Ibrutinib. Ibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of various B-cell malignancies, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It works by irreversibly binding to the BTK enzyme, blocking B-cell receptor signaling and inhibiting malignant B-cell proliferation and survival. Ibrutinib has demonstrated significant efficacy in both relapsed and treatment-naïve patients. It is administered once daily and has good oral bioavailability. Common side effects include diarrhea, fatigue, bleeding, hypertension, and atrial fibrillation. The drug may interact with CYP3A4 inhibitors, requiring dose adjustments. Ibrutinib represents a major advancement in targeted cancer therapy, offering durable responses and improved survival in B-cell cancers. Buy high quality Ibrutinib from Omsynth Lifesciences.